Regulation of Podocyte Injury by CircHIPK3/FUS Complex in Diabetic Kidney Disease

Diabetic kidney disease (DKD) is a major microvascular complication of diabetes mellitus and is one of the leading causes of end-stage kidney disease. Circular RNAs (circRNAs) are a class of endogenous non-coding RNAs that play important roles in various diseases, yet their roles in DKD are poorly understood. CircRNA HIPK3 (circHIPK3), a highly conserved circRNA, is closely related to various cellular functions, including cell proliferation and apoptosis. The association between circHIPK3 and diabetic complications has been well demonstrated in multiple previous studies. However, the role of circHIPK3 in podocyte injury in DKD remains unclear. Herein, we discovered that circHIPK3 expression is markedly elevated in cultured podocytes under high-glucose (HG) conditions and glomeruli of diabetic mice, which is closely associated with podocyte injury in DKD. Functionally, lentivirus-mediated knockdown of circHIPK3 dramatically suppresses HG-induced podocyte apoptosis in vitro. Therapeutically, silencing circHIPK3 by adeno-associated virus-mediated RNA interference ameliorates podocyte injury and albuminuria in STZ-induced diabetic mice. Mechanistically, circHIPK3 facilitates the enrichment of fused in sarcoma (FUS) on the ectodysplasin A2 receptor (EDA2R) promoter, resulting in the upregulation of EDA2R expression and activation of apoptotic signaling. Taken together, these results indicate circHIPK3/FUS/EDA2R axis as a therapeutic target for podocyte injury and DKD progression.

[1]  Feng Liu,et al.  Pathogenic Role of MicroRNA Dysregulation in Podocytopathies , 2022, Frontiers in Physiology.

[2]  Hui Tang,et al.  MAD2B promotes podocyte injury through regulating Numb-dependent Notch 1 pathway in diabetic nephropathy , 2022, International journal of biological sciences.

[3]  H. Hammes,et al.  MAD2B-mediated cell cycle reentry of podocytes is involved in the pathogenesis of FSGS , 2021, International Journal of Biological Sciences.

[4]  J. Jelsing,et al.  Integrative transcriptomic profiling of a mouse model of hypertension-accelerated diabetic kidney disease , 2021, Disease models & mechanisms.

[5]  A. V. van Zonneveld,et al.  Circular RNAs in kidney disease and cancer , 2021, Nature Reviews Nephrology.

[6]  J. Jelsing,et al.  Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease. , 2021, American journal of physiology. Renal physiology.

[7]  Yihan Fu,et al.  Biogenesis, cellular effects, and biomarker value of circHIPK3 , 2021, Cancer cell international.

[8]  P. Overbeek,et al.  PGC1α is required for the renoprotective effect of lncRNA Tug1 in vivo and links Tug1 with urea cycle metabolites , 2021, Cell reports.

[9]  D. Figeys,et al.  Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells , 2021, Autophagy.

[10]  Shuchen Zhang,et al.  Involvement of circHIPK3 in the pathogenesis of diabetic cardiomyopathy in mice , 2021, Diabetologia.

[11]  K. Tuttle,et al.  Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence , 2020, Nature Reviews Nephrology.

[12]  Xiaowen Chen,et al.  circRNA_010383 Acts as a Sponge for miR-135a, and Its Downregulated Expression Contributes to Renal Fibrosis in Diabetic Nephropathy , 2020, Diabetes.

[13]  Xiaowen Chen,et al.  circRNA_010383 Acts as a Sponge for miR-135a and its Downregulated Expression Contributes to Renal Fibrosis in Diabetic Nephropathy. , 2020, Diabetes.

[14]  Yi Fu,et al.  Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism. , 2020, Cell metabolism.

[15]  Shoujun Bai,et al.  Exosomal circ_DLGAP4 promotes diabetic kidney disease progression by sponging miR-143 and targeting ERBB3/NF-κB/MMP-2 axis , 2020, Cell Death & Disease.

[16]  G. Remuzzi,et al.  EGF receptor–mediated FUS phosphorylation promotes its nuclear translocation and fibrotic signaling , 2020, The Journal of cell biology.

[17]  Ling-Ling Chen.  The expanding regulatory mechanisms and cellular functions of circular RNAs , 2020, Nature Reviews Molecular Cell Biology.

[18]  Qin Jiang,et al.  Circular RNA-ZNF532 regulates diabetes-induced retinal pericyte degeneration and vascular dysfunction. , 2020, The Journal of clinical investigation.

[19]  W. He,et al.  EDA2R mediates podocyte injury in high glucose milieu. , 2020, Biochimie.

[20]  Hong-Hong Zhang,et al.  Circular RNA profile in diabetic peripheral neuropathy: analysis of coexpression networks of circular RNAs and mRNAs. , 2020, Epigenomics.

[21]  Weilong Chang,et al.  LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer , 2019, Gastric Cancer.

[22]  S. Houser,et al.  Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS/VEGF-A axis , 2019, Nature Communications.

[23]  M. Redd,et al.  Coronin 1A depletion restores the nuclear stability and viability of Aip1/Wdr1-deficient neutrophils , 2019, The Journal of cell biology.

[24]  Jørgen Kjems,et al.  The biogenesis, biology and characterization of circular RNAs , 2019, Nature Reviews Genetics.

[25]  Qin Jiang,et al.  Targeting pericyte–endothelial cell crosstalk by circular RNA-cPWWP2A inhibition aggravates diabetes-induced microvascular dysfunction , 2019, Proceedings of the National Academy of Sciences.

[26]  O. Mühlemann,et al.  The Solution Structure of FUS Bound to RNA Reveals a Bipartite Mode of RNA Recognition with Both Sequence and Shape Specificity. , 2019, Molecular cell.

[27]  Kai Huang,et al.  Cis-Acting circ-CTNNB1 Promotes β-Catenin Signaling and Cancer Progression via DDX3-Mediated Transactivation of YY1. , 2018, Cancer research.

[28]  D. Brenner,et al.  The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond. , 2019, Physiological reviews.

[29]  Xiao-ming Meng,et al.  Noncoding RNAs in acute kidney injury , 2018, Journal of cellular physiology.

[30]  M. Cooper,et al.  Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease. , 2018, Journal of the American Society of Nephrology : JASN.

[31]  K. Tuttle,et al.  Diabetic Kidney Disease: Challenges, Progress, and Possibilities. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[32]  Hui Tang,et al.  The classic signalling and trans‐signalling of interleukin‐6 are both injurious in podocyte under high glucose exposure , 2017, Journal of cellular and molecular medicine.

[33]  Shenmin Zhang,et al.  Circular Noncoding RNA HIPK3 Mediates Retinal Vascular Dysfunction in Diabetes Mellitus , 2017, Circulation.

[34]  M. Sisto,et al.  X-linked ectodermal dysplasia receptor (XEDAR) gene silencing prevents caspase-3-mediated apoptosis in Sjögren’s syndrome , 2017, Clinical and Experimental Medicine.

[35]  M. Heuser,et al.  Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  P. Overbeek,et al.  Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy. , 2016, The Journal of clinical investigation.

[37]  D. Corcoran,et al.  miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy , 2016, Nature Communications.

[38]  Yan Li,et al.  Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs , 2016, Nature Communications.

[39]  F. S. Foster,et al.  Foxo3 circular RNA promotes cardiac senescence by modulating multiple factors associated with stress and senescence responses , 2016, European heart journal.

[40]  Qiang Wan,et al.  MAD2B contributes to podocyte injury of diabetic nephropathy via inducing cyclin B1 and Skp2 accumulation. , 2015, American journal of physiology. Renal physiology.

[41]  M. Matsuoka,et al.  Overexpression of nuclear FUS induces neuronal cell death , 2015, Neuroscience.

[42]  Katalin Susztak,et al.  Molecular mechanisms of diabetic kidney disease. , 2014, The Journal of clinical investigation.

[43]  Jenny J. Yang,et al.  Identification of a Small Molecular Insulin Receptor Agonist With Potent Antidiabetes Activity , 2014, Diabetes.

[44]  Shanshan Zhu,et al.  Circular intronic long noncoding RNAs. , 2013, Molecular cell.

[45]  Karin J Jensen,et al.  Simultaneous Profiling of 194 Distinct Receptor Transcripts in Human Cells , 2013, Science Signaling.

[46]  N. Tomioka,et al.  Macrophage migration inhibitory factor is a possible candidate for the induction of microalbuminuria in diabetic db/db mice. , 2013, Biological & pharmaceutical bulletin.

[47]  Kinji Ohno,et al.  Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions , 2012, Scientific Reports.

[48]  Y. Koide,et al.  Coronin‐1a inhibits autophagosome formation around Mycobacterium tuberculosis‐containing phagosomes and assists mycobacterial survival in macrophages , 2012, Cellular microbiology.

[49]  H. Bussemaker,et al.  TLS/FUS (translocated in liposarcoma/fused in sarcoma) regulates target gene transcription via single-stranded DNA response elements , 2012, Proceedings of the National Academy of Sciences.

[50]  B. Spencer‐Dene,et al.  FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth. , 2011, Cancer research.

[51]  P. Chaudhary,et al.  X-Linked Ectodermal Dysplasia Receptor Is Downregulated in Breast Cancer via Promoter Methylation , 2010, Clinical Cancer Research.

[52]  J. Manley,et al.  The TET family of proteins: functions and roles in disease. , 2009, Journal of molecular cell biology.

[53]  Y. Furukawa,et al.  XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway , 2009, Oncogene.

[54]  B. Williams,et al.  Mapping and quantifying mammalian transcriptomes by RNA-Seq , 2008, Nature Methods.

[55]  P. Mathieson.  The podocyte as a target for therapies—new and old , 2012, Nature Reviews Nephrology.